Case File №
#VI-2026-0347
Hangzhou Youngpeptide Biotechnology HYB
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
44 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | E Bad | 7 | 5.5 | 0.0 | 8.0 | 5 Aug 2025 |
| Tirzepatide | E Bad | 8 | 6.5 | 0.0 | 8.6 | 20 Jun 2025 |
| 1-Boc-4-(4-fluorophenylamino)piperidine CAS 288573-56-8 | X N/A | 1 | 7.3 | 7.3 | 7.3 | 11 Jun 2025 |
| Adipotide | X N/A | 1 | 4.0 | 3.6 | 3.6 | 21 May 2025 |
| AICAR | X N/A | 1 | 8.6 | 8.6 | 8.6 | 17 Dec 2024 |
| Anadrol (Oxymetholone) | X N/A | 1 | 7.3 | 7.3 | 7.3 | 13 Feb 2025 |
| APAA (alpha-phenylacetoacetamide) CAS 102-01-2 | X N/A | 1 | 5.4 | 5.4 | 5.4 | 11 Jun 2025 |
| BMK methyl glycidate CAS 80532-66-7 | X N/A | 1 | 5.8 | 5.8 | 5.8 | 27 Feb 2025 |
| Boldenone Cypionate | X N/A | 1 | 7.2 | 7.2 | 7.2 | 13 Jun 2025 |
| Botulinum toxin | X N/A | 1 | 7.3 | 7.3 | 7.3 | 13 Feb 2025 |
| BPC157 10mg + TB500 10mg Blend | X N/A | 1 | 8.0 | 8.0 | 8.0 | 25 Apr 2025 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 1 | 7.8 | 7.8 | 7.8 | 3 Jul 2025 |
| Cartalax | X N/A | 1 | 7.0 | 7.0 | 7.0 | 7 May 2025 |
| Chonluten | X N/A | 1 | 4.7 | 4.7 | 4.7 | 28 Mar 2025 |
| CJC-1295 With DAC | X N/A | 1 | 8.2 | 8.2 | 8.2 | 6 May 2025 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | X N/A | 1 | 5.1 | 5.1 | 5.1 | 13 Jun 2025 |
| Clomid | X N/A | 1 | 8.1 | 8.1 | 8.1 | 13 Jun 2025 |
| Drostanolone Enanthate (Mast E) Raw | X N/A | 1 | 7.1 | 7.1 | 7.1 | 17 Dec 2024 |
| GHRP-2 Acetate | X N/A | 1 | 5.4 | 5.4 | 5.4 | 9 Jun 2025 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X N/A | 1 | 6.8 | 6.8 | 6.8 | 21 May 2025 |
| Halotestin (Fluoxymesterone) | X N/A | 1 | 7.9 | 7.9 | 7.9 | 7 May 2025 |
| Masteron P (Drostanolone P) | X N/A | 1 | 6.0 | 6.0 | 6.0 | 24 Apr 2025 |
| MENT (Trestolone Acetate) | X N/A | 1 | 8.7 | 8.7 | 8.7 | 3 Jul 2025 |
| Methylamine (base) CAS 74-89-5 | X N/A | 1 | 6.5 | 6.5 | 6.5 | 14 Jan 2025 |
| MGF | X N/A | 1 | 5.1 | 5.1 | 5.1 | 9 Jun 2025 |
| N-Acetyl Epitalon Amidate | X N/A | 1 | 6.5 | 6.5 | 6.5 | 2 Jul 2025 |
| NandroMix 300 | X N/A | 1 | 4.0 | 3.3 | 3.3 | 13 Feb 2025 |
| PE 22-28 | X N/A | 1 | 6.5 | 6.5 | 6.5 | 24 Apr 2025 |
| RAD140 | X N/A | 1 | 8.1 | 8.1 | 8.1 | 7 May 2025 |
| Retatrutide Raw | X N/A | 1 | 5.8 | 5.8 | 5.8 | 28 Mar 2025 |
| Selank 10mg + Semax 10mg Blend | X N/A | 1 | 5.8 | 5.8 | 5.8 | 13 Jun 2025 |
| Semax | X N/A | 1 | 7.1 | 7.1 | 7.1 | 8 Jul 2025 |
| Sustanon 250 | X N/A | 1 | 6.4 | 6.4 | 6.4 | 7 May 2025 |
| Sustanon Blend Raw | X N/A | 1 | 5.6 | 5.6 | 5.6 | 2 Jul 2025 |
| T4 (Levothyroxine) | X N/A | 1 | 5.4 | 5.4 | 5.4 | 2 Apr 2025 |
| Teriparatide | X N/A | 1 | 5.2 | 5.2 | 5.2 | 7 May 2025 |
| Test Enanthate | X N/A | 1 | 4.4 | 4.4 | 4.4 | 8 Jul 2025 |
| Testo 600 (Test Acetate 180mg+TPP 220mg+Cyp 200mg) | X N/A | 1 | 7.0 | 7.0 | 7.0 | 6 May 2025 |
| Testosterone Decanoate Raw | X N/A | 1 | 8.0 | 8.0 | 8.0 | 11 Jun 2025 |
| Thymalin | X N/A | 1 | 5.6 | 5.6 | 5.6 | 13 Feb 2025 |
| Thymosin Alpha-1 | X N/A | 1 | 6.9 | 6.9 | 6.9 | 9 Jun 2025 |
| Vilon | X N/A | 1 | 4.0 | 4.0 | 4.0 | 13 Jun 2025 |
| Vitamin B12 1mg/ml | X N/A | 1 | 5.6 | 5.6 | 5.6 | 6 May 2025 |
| Winstrol Oil | X N/A | 1 | 6.4 | 6.4 | 6.4 | 24 Apr 2025 |
Exhibit II
Evidence Log
49 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | APAA (alpha-phenylacetoacetamide) CAS 102-01-2 | 6.6 A | 100g | 90.1g | -9.9% | 97.78% | 9km9ha | Lab E | Community |
| 25 May 2026 | Clomid | 9.6 A | 50mg | 49.2mg | -1.6% | 99.91% | 6rfxfc | Lab G | Community |
| 25 May 2026 | MENT (Trestolone Acetate) | 10.0 A | 250mg/ml | 233.4mg/ml | -6.6% | 99.25% | ufi5yt | Lab G | Public |
| 25 May 2026 | NandroMix 300 | 6.4 A | 300mg/ml | 372.2mg/ml | +24.1% | 96.62% | 0fc1o4 | Lab D | Public |
| 24 May 2026 | 1-Boc-4-(4-fluorophenylamino)piperidine CAS 288573-56-8 | 8.1 A | 1g | 1.1g | +14.9% | 97.32% | difsep | Lab C | Public |
| 24 May 2026 | Halotestin (Fluoxymesterone) | 8.4 A | 20mg | 24.0mg | +20.1% | 95.27% | qqvxei | Lab D | Community |
| 24 May 2026 | Thymalin | 4.5 C | 20mg | 21.2mg | +6.1% | 95.41% | 19m6tg | Lab A | Public |
| 24 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 8.0 A | 20mg | 17.7mg | -11.3% | 96.82% | aramzo | Lab F | Public |
| 24 May 2026 | Winstrol Oil | 6.6 A | 200mg/ml | 184.0mg/ml | -8.0% | 97.28% | 5uw815 | Lab D | Community |
| 24 May 2026 | Adipotide | 4.0 C | 5mg | 5.3mg | +5.6% | 99.56% | m36kwy | Lab A | Public |
| 23 May 2026 | T4 (Levothyroxine) | 5.0 B | 10mg | 11.7mg | +17.0% | 97.80% | yahwqq | Lab E | Community |
| 23 May 2026 | Botulinum toxin | 5.4 B | 30mg | 30.0mg | -0.1% | 99.19% | 4w6702 | Lab E | Community |
| 23 May 2026 | Cartalax | 6.0 A | 30mg | 27.8mg | -7.2% | 96.35% | dj7hww | Lab D | Public |
| 23 May 2026 | Retatrutide Raw | 5.2 B | 1g | 1.2g | +23.8% | 97.45% | t430ic | Lab E | Public |
| 23 May 2026 | Selank 10mg + Semax 10mg Blend | 7.1 A | 10mg | 10.3mg | +2.8% | 95.36% | k3rbky | Lab F | Public |
| 21 May 2026 | Boldenone Cypionate | 7.4 A | 100mg/ml | 91.2mg/ml | -8.8% | 95.98% | i8pi4i | Lab G | Community |
| 21 May 2026 | BPC157 10mg + TB500 10mg Blend | 7.5 A | 2mg | 2.4mg | +20.0% | 99.90% | 41nff5 | Lab E | Public |
| 21 May 2026 | Methylamine (base) CAS 74-89-5 | 6.7 A | 5g | 5.3g | +6.0% | 96.09% | zurdnj | Lab D | Public |
| 21 May 2026 | MGF | 6.9 A | 20mg | 23.9mg | +19.6% | 97.48% | 6wk9rd | Lab C | Community |
| 21 May 2026 | Testosterone Decanoate Raw | 9.2 A | 1g | 0.9g | -10.2% | 97.65% | 5ya84y | Lab G | Public |
| 19 May 2026 | Retatrutide | 7.3 A | 20mg | 21.3mg | +6.5% | 99.80% | (no batch ID) | Lab G | Public |
| 19 May 2026 | Sustanon Blend Raw | 4.0 C | 500g | 613.7g | +22.7% | 96.48% | hxaehu | Lab C | Public |
| 17 May 2026 | CJC-1295 With DAC | 6.2 A | 10mg | 8.8mg | -11.8% | 98.62% | h75ukn | Lab E | Public |
| 29 Jan 2026 | AICAR | 7.7 A | 5mg | 4.9mg | -1.0% | 98.29% | cuuqd7 | Lab G | Community |
| 29 Jan 2026 | Test Enanthate | 4.5 C | 100mg/ml | 86.4mg/ml | -13.6% | 96.89% | 9gsgkg | Lab B | Public |
| 29 Jan 2026 | Thymosin Alpha-1 | 7.7 A | 20mg | 19.0mg | -4.9% | 98.85% | vj59j5 | Lab B | Public |
| 26 Jan 2026 | BPC157 5mg + TB500 5mg Blend | 7.2 A | 2mg | 2.3mg | +15.4% | 98.57% | cysvhw | Lab D | Public |
| 26 Jan 2026 | Semax | 6.0 A | 5mg | 6.0mg | +20.5% | 99.10% | f0sfas | Lab E | Public |
| 19 Jan 2026 | Masteron P (Drostanolone P) | 6.1 A | 200mg/ml | 187.1mg/ml | -6.5% | 99.37% | wqa7sq | Lab D | Community |
| 9 Jan 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 5.4 B | 20mg | 17.8mg | -10.8% | 97.98% | zgpxbi | Lab E | Public |
| 9 Jan 2026 | Testo 600 (Test Acetate 180mg+TPP 220mg+Cyp 200mg) | 6.6 A | 100mg/ml | 88.9mg/ml | -11.1% | 97.29% | c7840s | Lab F | Public |
| 7 Jan 2026 | Anadrol (Oxymetholone) | 7.3 A | 50mg | 47.7mg | -4.5% | 95.09% | afuq7k | Lab G | Community |
| 6 Jan 2026 | RAD140 | 8.1 A | 50mg | 48.2mg | -3.7% | 95.67% | 09azmb | Lab C | Community |
| 6 Jan 2026 | Teriparatide | 4.0 C | 15mg | 17.6mg | +17.0% | 96.37% | iasaos | Lab A | Community |
| 30 Dec 2025 | Retatrutide | 8.0 A | 30mg | 29.7mg | -1.0% | 99.88% | (no batch ID) | Lab E | Public |
| 29 Dec 2025 | Tirzepatide | 8.0 A | 20mg | 19.1mg | -4.5% | 99.95% | (no batch ID) | Lab E | Public |
| 29 Dec 2025 | Tirzepatide | 0.0 E | 60mg | ⚠️ Sample does not contain Tirzepatide ? | (no batch ID) | No Label / Copper Crimp / Clear Cap | Lab E | — | — |
| 18 Dec 2025 | Tirzepatide | 7.0 A | 60mg | 69.4mg | +15.7% | 99.70% | Oct 2, 2025 | Lab G | Public |
| 18 Dec 2025 | Tirzepatide | 8.6 A | 30mg | 27.9mg | -7.0% | 99.60% | Oct 2, 2025 | Lab G | Public |
| 17 Dec 2025 | Retatrutide | 7.4 A | 10mg | 9.8mg | -2.0% | 99.66% | (no batch ID) | Lab E | Public |
| 12 Dec 2025 | BMK methyl glycidate CAS 80532-66-7 | 4.0 C | 500g | 484.4g | -3.1% | 95.89% | 91ueel | Lab G | Community |
| 12 Dec 2025 | N-Acetyl Epitalon Amidate | 6.3 A | 15mg | 18.6mg | +24.0% | 98.66% | kjaujd | Lab D | Community |
| 12 Dec 2025 | Vitamin B12 1mg/ml | 5.9 B | 300mg/ml | 275.0mg/ml | -8.3% | 96.64% | jdnk8e | Lab F | Public |
| 5 Dec 2025 | PE 22-28 | 7.1 A | 20mg | 24.8mg | +24.1% | 98.59% | erexbv | Lab C | Public |
| 23 Nov 2025 | Drostanolone Enanthate (Mast E) Raw | 5.4 B | 100g | 123.1g | +23.1% | 99.21% | smlvfl | Lab D | Public |
| 23 Nov 2025 | Vilon | 4.0 C | 30mg | 25.7mg | -14.3% | 96.47% | 4en0xs | Lab A | Community |
| 14 Nov 2025 | GHRP-2 Acetate | 5.1 B | 30mg | 29.9mg | -0.4% | 99.96% | ij2jri | Lab G | Public |
| 4 Nov 2025 | Chonluten | 4.0 C | 30mg | 36.1mg | +20.2% | 99.12% | vlw8hm | Lab E | Community |
| 17 Oct 2025 | Sustanon 250 | 7.1 A | 100mg/ml | 115.7mg/ml | +15.7% | 96.41% | 7jwo8k | Lab C | Community |
— END OF EVIDENCE LOG —